Heart disease is a global pandemic affecting 26 million worldwide and increasing in prevalence. More effective front-line tools are needed to identify patients earlier while lowering costs for health systems. Current conventional ECG/EKG testing, the key front-line tool, has significant limitations for detecting 2 out of 3 categories of heart disease, ischemia (CAD) and structural heart disease. HeartSciences sits at the forefront of innovation and technological development focused on advancing the field of electrocardiology to provide early heart disease detection.
WHO IS HEARTSCIENCES:
• HeartSciences seeks to bridge today’s “diagnostic gap” in cardiac care by providing effective front-line solutions that assist in the detection of heart disease in at-risk patients.
• HeartSciences has invested heavily in research and development focused on advancing the field of electrocardiography through the use of technology to develop new algorithms focused on detecting cardiac conditions not previously available in ECG devices.
• Its first product, the MyoVista® Wavelet ECG (wavECG™) Cardiac Testing Device, is a resting 12-lead electrocardiograph that uses AI and continuous wavelet transform (CWT) signal processing to provide cardiac information associated with left ventricular diastolic dysfunction (LVDD), a condition which has previously not been possible to detect using conventional electrocardiology. LVDD is associated with almost all forms and co-morbidities of heart disease and may include hypertension, diabetes, valvular disease, ischemia, and reduced systolic function, among others.
Company Details
- Employees
- 20
- Founded
- -
- Address
- 550 Reserve Street,
- Phone
- 682-237-7781
- in****@****ces.com
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- heartsciences.com
- Keywords
- Medical Devices, Heart Disease Screening, Electrophysiology, Diastolic Dysfunction, Ejection Fraction, ECG, 12-Lead ECG, MyoVista Informatics, Continuous Wavelet Transform, Wavelet Signal Processing, Cardiac Dysfunction, Wavelet ECG, wavECG, Repolarization Abnormalities, Relaxation Abnormalities.
- HQ
- Southlake, Texas
Heartsciences (Nasdaq:hscs) Questions
Heartsciences (Nasdaq:Hscs)'s helpline number is 682-237-7781
Heartsciences (Nasdaq:Hscs)'s website is heartsciences.com
Heartsciences (Nasdaq:Hscs)'s LinkedIn profile is https://www.linkedin.com/company/heartsciences
Heartsciences (Nasdaq:Hscs) has
20 employees.
View email and phone details for 20
employees at Heartsciences (Nasdaq:Hscs).
Heartsciences (Nasdaq:Hscs)'s industry is
Medical Equipment Manufacturing
Heartsciences (Nasdaq:Hscs)'s top competitors are
Medtech Innovator,
Heartbeam Inc. (Nasdaq: Beat),
Alivecor,
Terarecon, Inc.,
Eko Health,
Dia Imaging Analysis - Acquired By Philips,
Proxima Cro,
Smartcardia,
Novacor,
Vista Ai.
Heartsciences (Nasdaq:Hscs)'s support email address is info@heartsciences.com
Heartsciences (Nasdaq:Hscs)'s categories are Medical Equipment Manufacturing
Heartsciences (Nasdaq:Hscs)'s founding year is 2008
